Lisinopril Tablets USP, 10 mg, 1000-count bottles, Rx Only, Manufactured for: Lupin Pharmaceutica...

FDA Recall #D-1536-2022 — Class II — September 13, 2022

Recall #D-1536-2022 Date: September 13, 2022 Classification: Class II Status: Terminated

Product Description

Lisinopril Tablets USP, 10 mg, 1000-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited, Nagpur- 441 108, India. NDC 68180-980-03

Reason for Recall

Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.

Recalling Firm

Lupin Pharmaceuticals Inc. — Baltimore, MD

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

11,802 1000-count bottles

Distribution

Product was distributed to major distributors/wholesalers nationwide.

Code Information

Lot # Q201182, exp. date March 2024

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated